The QualityStocks Daily Thursday, May 7th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (VGGOF) +142.08%

MarketBeat (TTPH) +74.10%

BUYINS.NET (GNUS) +73.90%

The QualityStocks Daily Stock List

EncounterCare Solutions, Inc. (ECSL)

GlobeNewswire, EIN Presswire, Street Insider, PetrolWorld.com, Research Pool, Wallmine, Barchart, OTC Markets, CSP Daily News, The Stock Market Watch, World Trading Data, YCharts, GuruFocus, Equities.com, TradingView, InvestorsHub, TipRanks, Stockwatch, and Wallet Investor reported beforehand on EncounterCare Solutions, Inc. (ECSL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

EncounterCare Solutions, Inc. is an Energy and Healthcare company. It operates its business through its Energy Division and its Healthcare Services Division. EncounterCare Solutions’ wholly-owned subsidiary is CyberFuels, Inc. EncounterCare formerly went by the name Ecare Solutions, Inc. It changed its name to EncounterCare Solutions, Inc. in November of 2000. EncounterCare Solutions is based in Palm Beach Gardens, Florida.

The Company’s Energy Division includes CyberFuels™, Inc. with its brand name EcoFlex 96™. CyberFuels' proprietary technology yielded notable fuel products sold under the brand name EcoFlex 96™. EcoFlex 96™ is available as blended fuel, and as a low cost high performance fuel replacement for E85. In addition, under special circumstances, it is available as a premium fuel as a direct replacement for gasoline.

EcoFlex96™ offers high octane alternatives to regular gasoline. The Company’s gasoline and alcohol blended fuels offer superior performance over similar traditional gasoline blends. Unlike other fuel options, there is no requirement to retrofit the vehicle for consumption of EncounterCare’s fuel blends. All of the Company’s fuels can be transported, stored, as well as pumped like regular gasoline.

The CyberFuels lines of products also includes its "Dynamo™" brands. Regarding Dynamo™ Diesel Cetane Booster, it is independent lab certified to decrease Diesel Particulate Matter (DPM) by 20 percent and overall emissions by 21 percent. It has been shown to deliver an average Cetane rating over 52 when added to regular diesel fuel at fill up. Furthermore, Dynamo™ Diesel Cetane Booster improves engine performance, power. It also increases miles per gallon along with improving cold flow, increasing lubricity and cleaning fuel injectors.

Dynamo™ Gasoline Octane Booster is also part of the Dynamo family. It improves octane and increases the miles per gallon (mpg). Dynamo™ Gasoline Octane Booster permits consumers to purchase regular 87 octane gasoline and increase the power and performance of that fuel to equal that of superior high test 93 octane gasolines, through adding a bottle of Dynamo™ Gasoline Octane Booster to their tank at fill up.

EncounterCare Solutions’ Healthcare Services includes Building Blocks Pediatric Home Health Services. This is a high-technology home care service exclusively for children - premature infants through adolescents. Building Blocks is the leading provider of purely pediatric home care in the State of California. It provides a comprehensive set of pediatric and neonatal services. This includes skilled nursing, home infusion, medical equipment, and more.

EncounterCare Solutions, Inc. (ECSL), closed Thursday’s trading session at $0.2447, up 11.2273%, on 85,895 volume. The average volume for the last 3 months is 43,290 and the stock's 52-week low/high is $0.080099999/$0.409999996.

chart

Ionix Technology, Inc. (IINX)

TradingView, OTC Markets, GuruFocus, OilandGas360, Financial Content, Wallet Investor, Market Exclusive, YCharts, Simply Wall St, Stocktube, Stockhouse, Last10k, Financial Buzz, Market Wire News, MarketWatch, Open Insider, Market Screener, Dividend Investor, Small Cap Exclusive, Stockopedia, Wallmine, Proactive Investors, The Street, Street Insider, and Morningstar reported earlier on Ionix Technology, Inc. (IINX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. The Company is focusing on becoming the business aggregator that primarily promotes photoelectric display, smart energy, and lead industrial technology development since restructuring. Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions. The Company previously went by the name Cambridge Projects, Inc. It changed its name to Ionix Technology, Inc. in February of 2016. Ionix Technology lists on the OTC Markets Group’s OTCQB.

The Company has five operating subsidiaries. One is Changchun Fangguan Electronics Technology Co., Ltd, a company that has been focusing on R&D, manufacturing and marketing LCM and LCD. Another is Changchun Fangguan Photoelectric Display Technology Co., Ltd. This subsidiary specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products.

Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd. It specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs. Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking. Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices.

Ionix Technology has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases, to capture the market share of OLED high technology. Changchun Fangguan is a foremost manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix Technology acquired control of Changchun Fangguan.

Recently, Ionix Technology announced updates of its two subsidiaries Shenzhen Baileqi Electronic Technology Co., Ltd. (Baileqi) and Lisite Science Technology (Shenzhen) Co., Ltd. (Lisite). Because of the growing demand for online education, live webcasts, and online communication platforms, Baileqi has received an increased amount of orders in the past few months for its LCD modules. These are the key components of the remote communication terminals. Additionally, Baileqi plays a vital role in Ionix Technology’s OLED module project.

At present, Lisite is developing a battery management system (BMS), which can be applied to existing battery pack production lines and electric logistics vehicles. The new product is expected to bring a new revenue source for Lisite.

Ionix Technology, Inc. (IINX), closed Thursday’s trading session at $1.90, even for the day, on 300 volume with 00 trades. The average volume for the last 3 months is 1,998 and the stock's 52-week low/high is $0.699999988/$2.18000006.

chart
n

Oranco, Inc. (ORNC)

Simply Wall St, Research Pool, Stockhouse, Dividend Investor, TeleTrader, OTC Markets, last10k, BigDataVendors, NewsQuantified, VentureLine, Invezz, Barchart, InvestorsHub, Seeking Alpha, GuruFocus, Morningstar, TradingView, Stockwatch, YCharts, TradingCharts.com, Ready Ratios, Stockopedia, Wallet Investor, Globe Newswire, and Nasdaq reported previously on Oranco, Inc. (ORNC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Oranco, Inc. engages in the marketing and wholesale of self-branded liquors and wines in China. The Company offers Chinese Fenjiu liquor under the Dagangjiu brand name, and also imported wines. Its aim is to promote premium alcoholic beverages to China’s population. It sells its products by way of distributors. Incorporated in 1977, the Company lists on the OTC Markets. Oranco is based in Fenyang City, China.

Oranco’s current focus is the sale of self-branded Fenjiu liquor and imported wines. The Company is working to achieve its above-stated goal through catering to the ever- developing tastes in alcohol via its creative marketing strategies and inventive product designs that target different age groups in China.

Oranco has developed different unique products, such as its “Dagangjiu” (translated as “Big Jar Liquor”). The Company is continually renovating traditional Chinese culture to attract various age and cultural groups in China.

Oranco has launched its blockchain-based anti-counterfeiting laser recognition proprietary technology (the “Huaxin Cellar Blockchain ”) and E-Commerce Trading Platform powered by the Huaxin Cellar Blockchain. The Huaxin Cellar Blockchain had completed its testing phase. Oranco plans to launch the Huaxin Cellar Blockchain platform soon. The Huaxin Cellar Blockchain offers advantages in terms of securing the authenticity of Oranco’s alcoholic beverage products. These advantages include tamper-proof transaction information, traceable circulation records, and permanent certificates records.

The Platform is a high-end online and offline ecological system for alcoholic beverages transactions. It increases customers’ confidence in their spirits and wine purchases through providing transparent pricing and reliable shopping channels.

Last month, Oranco announced that Alibaba Hong Kong Limited, Gold Supplier Service executed an agreement with Oranco to distribute a select number of their liquor portfolio items throughout Western Europe. This includes Russia, Ukraine, Turkey, and Poland. The products will be distributed through Alibaba’s Gold Supplier Service and their export marketing solutions. The overall service will help Oranco to gain maximum exposure online in numerous markets.

Oranco, Inc. (ORNC), closed Thursday’s trading session at $0.65, even for the day, on 700 volume. The average volume for the last 3 months is 405 and the stock's 52-week low/high is $0.300000011/$3.29999995.

chart

Rapid Nutrition Plc. (RPNRF)

Spotlight Growth, OTC.Watch, PR Newswire, Market Screener, Wallet Investor, OTC Markets, Nasdaq, Small Cap Voice, Stockaholics, InvestorsHub, Penny Stock Hub, Barchart, YCharts, Dividend Investor, GlobeNewswire, PharmiWeb, PennyStocks.news, Business Insider, GuruFocus, New Media Wire, Financial Buzz, Seeking Alpha, Central Charts, and TradingView reported earlier on Rapid Nutrition Plc. (RPNRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rapid Nutrition Plc. is a natural healthcare company based in London, United Kingdom. It focuses on the research, development, and production of a range of life science products. In 2001, Mr. Simon St Ledger (a personal trainer and dietary consultant), and the Chief Executive Officer, founded Rapid Nutrition in Australia. The Company’s core business is the creation of organic and natural scientific-based health food supplements and building them into recognized brands. Rapid Nutrition lists on the OTC Markets’ OTCQB.

Rapid Nutrition was formed based on its successful and proven weight loss supplement range. This is exported globally. The Company now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns. In addition, it provides a number of wider services to the life sciences industry. Rapid Nutrition has registered products in and/or exported its products to Australia, Asia, Europe, the Middle East, Africa, and the United States.

Rapid Nutrition entered into a joint venture (JV) agreement with Motivate Health Technology, Inc. in 2012 to distribute System LS™ products directly to U.S. customers. In 2013, the Company won the Australian government export awards and was recognized as national finalist in the biotechnology sector.

Rapid Nutrition had expanded distribution into markets in Asia, Europe, Africa, and the Middle East by 2014. In 2015, the Company successfully formulated and launched the System LS™ in Australia and the United States. Over 2016 and 2017, Rapid Nutrition started and completed the development of a range of certified vegan protein formulas. The vegan certified protein powder adds an additional product extension to its current flagship brand System LS™. Rapid Nutrition secured the Exclusive Master Distribution rights for Australia with General Nutrition Corporation (GNC) in 2018.

This week, Rapid Nutrition announced it will launch a new oral anti-viral treatment called Azurene designed to combat influenza and the common cold in humans. Rapid Nutrition is in discussions with the Australian government and top universities to conduct further testing. Independent testing at two laboratories has already confirmed the product's strong antiviral activity and a provisional patent application has been filed.

Azurene is the product of years of research based on in-vitro testing, scholarly literature and continuing clinical trials ahead of product launch. The expectation is that the anti-viral and anti-inflammatory formula will be safe for use among all ages, including children and seniors.

Rapid Nutrition Plc. (RPNRF), closed Thursday’s trading session at $0.1081, even for the day, on 3,731 volume. The average volume for the last 3 months is 1,393 and the stock's 52-week low/high is $0.090999998/$0.531000018.

chart

Sandfire Resources America, Inc. (SRAFF)

Proactive Investors, Stock Pulse, Street Insider, Junior Mining Network, Market Screener, Stockopedia, YCharts, TradingView, Investors Hub, Annual Reports, Stockhouse, Northern Miner, and Simply Wall St reported earlier on Sandfire Resources America, Inc. (SRAFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sandfire Resources America, Inc. acquires, explores for, and develops resource properties in the United States and Canada. It explores for copper, cobalt, zinc, lead, and silver deposits. Its flagship property is the Black Butte copper project. The Company formerly went by the name Tintina Resources, Inc. It changed its corporate name to Sandfire Resources America, Inc. in January of 2018. Established in 1998, Sandfire Resources America is based in White Sulphur Springs, Montana.

The Black Butte copper project comprises approximately 7,684 acres of fee-simple lands and 4,541 acres in 239 Federal unpatented lode-mining claims situated in central Montana. Located north of White Sulphur Springs, the project’s property includes the Johnny Lee Deposit, which contains a copper concentration 10 times higher than many existing mines. The Black Butte Copper Project will be an underground mine.

The Johnny Lee deposit has a Measured and Indicated Mineral Resource of 10.9 million tonnes (Mt) at an average copper grade of 2.9% for 311 thousand tonnes (kt) of contained copper (Cu) at a 1.0 % Cu cut-off grade. The Johnny Lee deposit also has an Inferred Mineral Resource of 2.7 Mt at an average copper grade of 3.0% for 80 kt of contained Cu at a 1.0 % Cu cut-off grade.

Forty-eight diamond drill holes completed by Sandfire Resources America have been used to update the Mineral Resource estimate for the Johnny Lee deposit. Metallurgical testing of the deposit has been integrated with systematic mineralogy to develop a copper recovery model. The updated copper cut-off grade of 1.0 % Cu is based upon updated recovery studies and price assumptions.

Recently, Sandfire Resources America advised that it achieved two key permitting milestones for the Black Butte Copper underground mining project in Montana. On March 13, 2020, two Montana Government agencies each issued important components of the overall permitting process for the Black Butte Copper project that are key to the Company receiving a Record of Decision (RoD) for its Mine Operating Permit (MOP).

First is the release of Final Environmental Impact Statement (EIS) by the Montana Department of Environmental Quality (MTDEQ). Second, the Department of Natural Resources & Conservation (MTDNRC) issued a Preliminary Determination (PD) in response to the water right owners’ application to modify their irrigation water rights to include leasing water for mitigation for the Black Butte Copper project.

Last month, Sandfire Resources America announced that the Black Butte Copper underground mining project in Montana received a Record of Decision for its permit. On April 9, 2020, the Montana Department of Environmental Quality (MTDEQ) released a positive Record of Decision (RoD) to grant a Mine Operating Permit to Sandfire’s wholly-owned subsidiary, Tintina Montana, Inc. This will allow development and underground mining of the Johnny Lee deposit at the Black Butte Copper Project to proceed.

Sandfire Resources America, Inc. (SRAFF), closed Thursday’s trading session at $0.2002, off by 0.049925%, on 12,500 volume. The average volume for the last 3 months is 61,362 and the stock's 52-week low/high is $0.064999997/$0.309300005.

chart

School Specialty, Inc. (SCOO)

NetworkNewsWire, Wallmine, TipRanks, Trading View, Zacks, Morningstar, Tech Know Bits, last10k, Market Screener, Barchart, Stockopedia, MarketWatch, Capital Cube, Annual Reports, Wallet Investor, GlobeNewswire, MarketBeat, Simply Wall St, Stockhouse, Dividend.com, and Proactive Investors reported previously on School Specialty, Inc. (SCOO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

School Specialty, Inc. is a top provider of unique products and solutions that support integrated learning environments for improved student social, emotional, mental, and physical well-being. The Company serves teachers, curriculum specialists, individual schools, school districts, parents, and administrators in various healthcare related markets. School Specialty’s educational products and services are for the Pre-K- 12th grade. Established in 1959, School Specialty is headquartered in Greenville, Wisconsin. The Company’s shares trade on the OTCQB.

School Specialty serves the United States and Canada through a comprehensive network of distribution centers powered by a multi-channel approach. The Company designs, develops, and delivers the widest variety of innovative and proprietary products, programs, and services to the education marketplace. This includes essential classroom supplies, furniture, educational technology, supplemental learning resources, science-based curriculum, and evidence-based safety training & security.

School Specialty offers its own proprietary products from best-in-class brands such as Sax art products, SSI Guardian, Childcraft furniture, Frey, FOSS Science Curriculum, and School Smart, as well as some of the most trusted third-party brands in the educational marketplace. The Company has grown into an enterprise that includes greater than 70 subject matter experts and other industry thought leaders always seeking out and sharing leading-edge ideas to advance contemporary education.

In April, School Specialty provided results for its fiscal Q4 and fiscal year ended December 28, 2019. Revenue was $626.3 million for the fiscal year ended December 28, 2019, versus $673.5 million in fiscal 2018. This represents a decrease of 7.0 percent.

Fiscal Q4 2019 Revenue of $91.0 million was down 20.6 percent versus the prior year period. Nonetheless, the impact of prior year fulfillment center issues resulted in delaying more than $10.0 million of shipments from Q3 into Q4 2018.

Mr. Ryan Bohr, Executive Vice President and Chief Operating Officer of School Specialty, stated, “The core takeaways from our 2019 performance are that we delivered very effectively for our customers during the back-to-school season and successfully executed pricing and business strategies that had begun to steadily improve our margins in the second half of the year and position us for growth. Success in these areas had contributed to an exceptionally strong start to 2020 however this was curtailed by the global COVID-19 pandemic.”

School Specialty, Inc. (SCOO), closed Thursday’s trading session at $0.08, even for the day, on 18,566 volume. The average volume for the last 3 months is 66,258 and the stock's 52-week low/high is $0.032999999/$6.30000019.

chart

USA Truck, Inc. (USAK)

Equities.com, GlobeNewswire, Business Insider, Stocktwits, StockNews, MacroTrends, Street Insider, Morningstar, Talk Business, Seeking Alpha, Simply Wall St, Annual Reports, Nasdaq, Biz Journals, and Dividend Investor reported previously on USA Truck, Inc. (USAK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

USA Truck, Inc. provides comprehensive capacity solutions to a wide-ranging and diverse customer base across North America. The Company’s Trucking and USAT Logistics divisions blend an extensive portfolio of asset and asset-light services. This provides a balanced approach to supply chain management including customized truckload, dedicated contract carriage, intermodal, and third-party logistics freight management services. USA Truck is based in Van Buren, Arkansas. The Company lists on the NasdaqGS.

USA Truck has substantial Mexico Transborder experience. USAT Capacity Solutions coordinates transportation into and out of Mexico with its broad carrier network. It services most major Mexican markets.

Regarding Dedicated Transportation, USAT Capacity Solutions provides customized Dedicated solutions to meet the unique needs of businesses and their industries. USAT Capacity Solutions manages all aspects of the operation. This includes cost, regulations compliance, service performance and more. USAT works with customers of all sizes. Its scalable solutions improve the efficiency and flexibility of a customer’s distribution network, while delivering award-winning service.

Concerning Over The Road Services, USAT Capacity Solutions provides innovative solutions behind the strength of one of the nation’s largest over-the-road TL fleets. This includes USA Truck and Davis Transfer Company. The Company has broad experience in transporting goods from manufacturers in a wide assortment of industries.

USA Truck’s Logistics Division focuses entirely on its Brokerage and Intermodal services. This Division matches customer needs with available equipment from its network of carriers. The Logistic Division’s capacity-based rating strategy concentrates on managing a client’s costs through arranging for the cost-effective transportation of all types of freight with one call.

Regarding Intermodal, USAT Capacity Solutions’ Intermodal service provides flexible capacity solutions to benefit a business. It combines the best of both modes – its trucking assets blended with a single expedited segment on the rail. This is to provide differentiated service, reduce a customer’s carbon footprint, and add value to their supply chain while helping them meet their transit goals.

Recently, USA Truck announced that Mr. Zachary King was appointed to Senior Vice President and Chief Financial Officer. Mr. King has served as the Company’s Vice President and Corporate Controller since 2017. He has been with the Company since 2015. He succeeds Mr. Jason Bates, who is leaving the Company to pursue other opportunities. Before joining USA Truck, Mr. King served in an array of finance and accounting roles for ABB Ltd, Samson Resources Corporation, and Deloitte.

USA Truck, Inc. (USAK), closed Thursday’s trading session at $4.35, off by 1.8059%, on 26,902 volume. The average volume for the last 3 months is 46,493 and the stock's 52-week low/high is $2.35999989/$14.2899999.

chart

Braveheart Resources, Inc. (RIINF)

Zacks, Junior Mining Network, Gold Stock Data, The Gold Telegraph, Stock Pulse, The Prospector News, Morningstar, TMXmoney, Mining and Energy, Proactive Investors, Stockhouse, 4-Traders, Seeking Alpha, TradingView, Investors Hangout, Simply Wall St, Nasdaq and Investing News reported earlier on Braveheart Resources, Inc. (RIINF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Braveheart Resources, Inc. is a junior mining company focused on building shareholder value through exploration and development in the favourable and proven mining jurisdictions of the East and West Kootenays of British Columbia. It explores for gold, copper, and silver deposits. The OTCQB-listed Company formerly went by the name Rainbow Resources, Inc. It changed its name to Braveheart Resources, Inc. in November of 2014. Braveheart Resources is based in Calgary, Alberta.

Braveheart’s chief asset is the Bull River Mine project that has a current mineral resource containing copper, gold and silver. The property is completely developed with 21,000 meters of underground developments in terms of ramps, raises and drifting on mineralized structures on seven levels. The surface infrastructure at the Bull River Mine project includes a 750 tonne per day conventional mill with adjoining crushing facilities and offices and mine maintenance facilities.

The Bull River Mine property is connected to grid power. In addition, there is year-round access to the site by paved and all-weather roads. The Bull River Project has an Indicated Resource of 1.51 M tonnes @ 2.263 % Cu Eq. It has an Inferred Resource of 0.34 M tonnes @1.86% Cu Eq.

The Bull River Mine Project has a large land package including several past producers - 9,800 hectares. There is the potential to recover cobalt in a pyrite/cobalt concentrate. The Property is 100 percent owned by Braveheart Resources.

Furthermore, Braveheart Resources is pursuing the development of its Alpine Mine property near Nelson, British Columbia. This is a past producing, high grade, underground gold mine. The Company’s intention is to truck the Alpine Mine ore to the newly acquired Bull River Mill located in Cranbrook, British Columbia.

This past January, Braveheart Resources announced that it raised proceeds of $171,711 via the exercise of 1,144,742 warrants at CDN$0.15 per share. It earlier issued 25,994,880 warrants on January 19, 2019 as part of a plan of arrangement in its purchase of Purcell Basin Minerals. The warrants had an expiry date of January 20, 2020. Each warrant entitled the holder to purchase a common share of Braveheart Resources at a price of CDN$0.15 per share. Proceeds will be used to continue with permitting activities at the Bull River Mine Project and for general corporate and administrative costs.

Braveheart Resources, Inc. (RIINF), closed Thursday’s trading session at $0.052, up 73.3333%, on 400 volume. The average volume for the last 3 months is 1,000 and the stock's 52-week low/high is $0.029999999/$0.141599997.

chart

Bankers Cobalt Corp. (NDENF)

OTC Markets, VentureCapNews, Penny Stock Hub, InvestorX, Streetwise Reports, TalkMarkets, The Prospector News, 4-Traders, Current Charts, Investor Place, Market Screener, Junior Mining Network, Energy and Capital, Stockhouse, PR Newswire, Wallet Investor, TipRanks, Barchart, Dividend Investor, TradingView, Morningstar, GlobeNewswire, Investing Online, Nasdaq, Seeking Alpha, Simply Wall St, and Investors Hub reported previously on Bankers Cobalt Corp. (NDENF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Bankers Cobalt Corp. is a cobalt and copper (Co-Cu) exploration and development enterprise listed on the OTC Markets’ OTCQB. It focuses on advancing its high quality portfolio of permitted concessions in the Democratic Republic of Congo (DRC). Bankers Cobalt is working to produce a reliable, certified, and socially responsible supply of Co-Cu for existing and new processors in the DRC. The Company has its head office in Vancouver, British Columbia.

Bankers Cobalt is building a portfolio of assets that will provide clean, certified, and non-conflict Co-Cu supply in an interdependent relationship with DRC based processors with existing excess capacity and a lack of available certified resources to meet escalating market demands. The Company has a 191 km2 portfolio Co-Cu concessions in the DRC - one of the early movers actively exploring and developing Co-Cu in the DRC. It has a portfolio of 9 concessions strategically positioned with clean title.

Bankers Cobalt’s value proposition includes acquiring, exploring, and developing valuable CO-CU assets worldwide. It also includes selling clean, conflict-free high quality supply to smelters. Furthermore, it includes maintaining ongoing and synergetic relationships with existing smelters. The Company acquires high quality projects in the DRC. It subsequently develops them by applying Canadian standard highly professional exploration techniques.

Bankers Cobalt has its “Concession - Comipad Comima CMTC (ZEA 292).” Ownership is 70/30 JV between the Company and three cooperatives. Its location is 6 km2-35 km southwest of Likasi with access by paved road and tracks.

In August 2019, Bankers Cobalt announced incentive stock option grants and provided a property update. It announced the grant of 512,500 incentive stock options to certain of its Directors, Officers, Consultants and Employees pursuant to its Stock Option Plan. These options are exercisable for a period of five years at a price of CAD$0.05 per share. Insiders of the Corporation cancelled 3,250,000 earlier issued incentive stock options.

Moreover, the Company, further to a news release dated May 15, 2019, and after completion of due diligence, determined to not proceed with the M’Sesa tailings project in the in the DRC. Bankers Cobalt will concentrate on larger near-term copper and cobalt cash flow opportunities in the DRC.

Bankers Cobalt Corp. (NDENF), closed Thursday’s trading session at $0.00705, up 220.4545%, on 1,000 volume. The average volume for the last 3 months is 5,790 and the stock's 52-week low/high is $0.002099999/$0.028799999.

chart

Ascent Solar Technologies, Inc. (ASTI)

Zacks, Microcap Daily, Stocktwits, CSIMarket, Stock of the Week, Infront Analytics, Investing.com, The Wolf Of Penny Stocks, Ready Ratios, OTC.Watch, Morningstar, InvestorsHub, Economies.com, Equities.com, Nasdaq, Insider Financial, Dividend Investor, Proactive Investors, Stockwatch, Simply Wall St, Seeking Alpha, GuruFocus, Stockhouse, Green Leaf Pot Stocks, TradingView, Wallet Investor, and YCharts reported beforehand on Ascent Solar Technologies, Inc. (ASTI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Ascent Solar Technologies, Inc. is a developer and manufacturer of state-of-the-art, lightweight, and flexible thin-film photovoltaic (PV) solutions. It designs, manufactures, and sells PV integrated consumer electronics and portable power applications for commercial and military users. The Company markets and sells its products via distributors, value added resellers, as well as e-commerce companies.

Established in 2005, Ascent Solar Technologies is based in Thornton, Colorado, where its Research and Development (R&D) and its 30 MW nameplate production facility are. Ascent Solar modules were named as one of the top 100 technologies in both 2010 and 2015 by R&D Magazine. In addition, they were named one of TIME Magazine's 50 best inventions for 2011.

The Company is a developer of thin-film PV modules using flexible substrate materials that are more versatile and sturdy than traditional solar panels. The technology represents the leading edge of flexible power. It can be directly integrated into consumer products and off-grid applications, and also other aerospace applications. Ascent Solar Technologies provides solar solutions from bare modules to finished goods and everything in between.

The Company has its patented 3-step manufacturing process. Step 1 is thin-film deposition. Step 2 is monolithic integration. Step 3 is final assembly. Ascent’s inventive monolithic integration process enables the highest level of efficiency, durability and weight savings. This represents the potential to transform the way solar power can be used in everyday life. The Company’s solar technology and power solutions are for remote locations and extreme environments. Regarding its IP (Intellectual Property), Ascent Solar Technologies has more than 80 U.S. and International issued patents and published patent applications.

Ascent develops and manufactures its innovative CIGS (Copper-Indium-Gallium-Selenide) photovoltaic technology on a flexible, plastic substrate. The design of these panels are to convert sunlight into electric power through laying a thin layer of these four elements onto a plastic backing.

The Company is a leader in the CIGS field. It is the only manufacturer commercially producing CIGS solar on a plastic substrate with monolithic integration, which is an important differentiator for the Company.

Ascent Solar Technologies, Inc. (ASTI), closed Thursday’s trading session at $0.0002, up 100.00%, on 55,017,647 volume. The average volume for the last 3 months is 23,827,552 and the stock's 52-week low/high is $0.000000999/$0.002249999.

chart

MTB Corp. (BANM)

Zacks, Stock Twits, Morningstar, Barchart, Stockhouse, Equities.com, GuruFocus, InvestorsHub, Street Insider, Annual Reports, Dividend Investor, Seeking Alpha, YCharts, Investing.com, TradingView, and Simply Wall St reported earlier on MTB Corp. (BANM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MTB Corp. is a fully integrated U.S. energy services company. It provides transportation, equipment rental, and other services to oil and gas producers. The Company has operations in Texas, Louisiana, Oklahoma and Pennsylvania. MTB Corp. lists on the OTC Markets. The Company is based in Frisco, Texas.

MTB does business as Banner Energy Services Corp. Banner Energy Services provides a broad variety of leading-edge production solutions and services. Banner offers transportation of frac sand and logistics services to hydraulic fracturing and drilling operators. In addition, it obtains and finances equipment to oilfield transportation services contractors.

Mr. Jay Puchir is President and Principal Financial Officer of Banner Energy Services. He is responsible for the Company’s executive leadership, mergers & acquisitions (M&As), capital allocation, performance management, as well as financial reporting. Most recently, Mr. Puchir served as the Chief Executive Officer and Chief Financial Officer of Ecoark Holdings (OTCQX: ZEST).

Mr. JD Reedy is the Chief Operating Officer of Banner Energy Services. Mr. Reedy oversees day-to-day operations, programs, and services. He is accountable for developing and executing sales and service plans to boost market growth for Banner. Mr. Reedy has a wide-ranging background in business development, field operations, and expanding market share within oil & gas service industries.

This past November, Banner Energy Services announced that it closed its earlier announced Merger with a subsidiary of Mount Tam Biotechnologies, Inc., effective November 18, 2019. Banner is the surviving entity and it becomes a subsidiary of Mount Tam.

Mount Tam received approval from its Board of Directors and shareholders and from FINRA for a name change to MTB Corp. and a reverse split of its common stock at a ratio of one new share for each 95 existing shares. On November 14, 2019, the reverse split and name change to MTB Corp. took effect. Moreover, the Company will take action to change the name from MTB Corp. to Banner Energy Services Corp.

MTB Corp. (BANM), closed Thursday’s trading session at $0.75, up 200.00%, on 1,445 volume. The average volume for the last 3 months is 529 and the stock's 52-week low/high is $0.200000002/$7.59049987.

chart

Dais Analytic Corp. (DLYT)

HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally,  PennyInvest, PennyStockVille, and Greenbackers  reported  earlier on Dais Analytic Corp. (DLYT), and  today we are highlighting the Company , here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.  

  The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product). 

In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.  Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.

The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component. 

  NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less. 

  Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.

  This past summer, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.

Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.

High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.

Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."

Dais Analytic Corp. (DLYT), closed Thursday’s trading session at $0.35, up 116.0494%, on 5,121 volume. The average volume for the last 3 months is 703 and the stock's 52-week low/high is $0.100000001/$18.5799999.

chart

OncBioMune Pharmaceuticals, Inc. (OBMP)

MissionIR, Otcstockexchange, Whisper from Wall Street, and Journal Transcript reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products globally. OncBioMune has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company incorporates scientifically proven and clinically validated treatments for cancer. OncBioMune Pharmaceuticals is based in Baton Rouge, Louisiana. The Company lists on the OTCQB.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™. This is its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program.

ProscaVax consists of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).

Moreover, the Company has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs. OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients.

OncBioMune states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.

In September 2017, OncBioMune Pharmaceuticals announced that it successfully attained development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA). This is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL). The Company owns the commercialization rights for tretinoin throughout Mexico, Central America, and Latin America.

Earlier this month, OncBioMune Pharmaceuticals provided the latest data from its successfully completed Phase 1 trial of ProscaVax for prostate cancer, suggesting a durable response 31 weeks post-therapy. In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with rising prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

Dr. Jonathan Head, Chief Executive Officer at OncBioMune Pharmaceuticals, said, “I’m very excited about this data, as I can’t think of another study to have 75 percent of recurrent prostate cancer patients with rising PSA experience stable disease nearly eight months after therapy ended. .. Now, we have to expand the therapeutic range and increase the number of patients enrolled in mid-stage research, but the data to date certainly is encouraging to provide a safe and effective treatments for the millions of men battling prostate cancer today.”

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Thursday’s trading session at $0.13, up 116.6667%, on 303 volume. The average volume for the last 3 months is 5,782 and the stock's 52-week low/high is $0.059999998/$7.875.

chart

Cryptologic Corp. (VGGOF)

Penny Stock Hub, CryptoSwan, OTC Markets, StockPulse, Stock Digest, Stockwatch, Morningstar, Stockhouse, Wallet Investor, Investors Hangout, Midas Letter, and Wallmine reported previously on Cryptologic Corp. (VGGOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cryptologic Corp. operates its cryptocurrency mining activities in the Province of Québec and the Company is Canada’s fastest growing miner. This includes mining for cryptocurrencies for its own account and within mining pools. At present, Cryptologic has roughly 23,000 Bitmain Antminer S9’s actively mining for its own account, producing about 295 Petahashes per second (PH/s) of hashing power.

Cryptologic lists on the OTC Markets Group’s OTCQB. The Company previously went by the name Vogogo, Inc. It changed its name to Cryptologic Corp. in July of 2019. Cryptologic has its corporate office in Toronto, Ontario.

Cryptologic has developed two modern cryptocurrency mining facilities powered with low-cost, clean energy. Its facilities were designed with the latest cryptocurrency mining data center techniques and optimizations. The Company’s facilities have been designed with modern electrical and HVAC techniques for cryptocurrency mining.

Additionally, Cryptologic develops hashrate optimization software and data center management software. Its proprietary software optimizes hashrate and its monitoring systems alert of any issues in the datacenter.

Cryptologic’s mission is to build applications and services that are vital to the Bitcoin ecosystem and its stakeholders. The Company’s vision is to quickly improve the usability of cryptocurrencies and blockchain applications and hasten their adoption.

Cryptologic has increased its mining operations from 4,125 S9’s, which produced about 50 PH/s to roughly 23,000 S9’s and 295 PH/s. This represents more than 450 percent growth.

On April 29, 2019, the Régie de l’énergie in Québec issued its decision for the blockchain file, providing certainty regarding electricity rates for Cryptologic in Québec. The Regulator confirmed Cryptologic’s industrial hydro electric rates (LG and M) from Hydro Quebec will not be increased.

Earlier in August, Cryptologic announced the proposed acquisition of the Canadian assets of Wayland Group. Cryptologic announced that it entered into a non-binding letter of intent (LOI) with Wayland Group (CSE:WAYL) relating to a proposed acquisition of Wayland’s Canadian business. This includes its Langton, Ontario production facilities and the assumption of liabilities related to Wayland’s Canadian business.

Wayland Group is a vertically integrated cultivator and processor of cannabis, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation and distribution business under federal licenses from the Government of Canada. The expectation is that, before closing, Cryptologic will sell the business and assets comprising its existing cryptocurrency mining and other operations and that, subject to and following closing of the acquisition transaction, it will be a single-purpose cannabis company.

Mr. John Kennedy FitzGerald, President and Chief Executive Officer of Cryptologic, said, “The recent improvement in market conditions for crypto assets has allowed Cryptologic to improve its cash position. Based on future uncertainty faced by crypto miners, management believes this is an optimal time to divest its crypto assets and complete a pivot of the business into the cannabis sector.”

Furthermore, this month, Wayland Group and Cryptologic announced that Wayland has received the earlier announced $5 million bridge loan from Cryptologic. It has been advanced in connection with the proposed sale of Wayland’s Canadian business to Cryptologic.

Cryptologic Corp. (VGGOF), closed Thursday’s trading session at $0.359, up 142.0769%, on 10,767 volume. The average volume for the last 3 months is 1,574 and the stock's 52-week low/high is $0.095600001/$2.60500001.

chart

The QualityStocks Company Corner

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, announced today that its wholly-owned subsidiary, Integra Pharma Solutions, LLC, has formally withdrawn its Emergency Use Authorization (EUA) application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to U.S. Food and Drug Administration (FDA) guidance. The decision to withdraw the EUA application was made after much discussion with its partnered manufacturer. Per FDA guidance, only one EUA application is allowed per manufactured kit product. 

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Thursday’s trading session at $6.40, up 0.31348%, on 48,750 volume. The average volume for the last 3 months is 138,365 and the stock's 52-week low/high is $2.70000004/$11.6000003.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioScience (OTCQB: PBIO) today announced the appointment of personal care industry leader Jim Morrison to serve as the new CEO of the rebranded public company, with intended corporation name of Availa Bio, upon completion of the merger with Cannaworx, SkinScience Labs and Pressure BioSciences. Morrison’s career includes numerous leadership positions in the personal care industry., most notably as President of L'Oréal where he oversaw growth that averaged more than 20% year-over-year. In addition, Morrison engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth. To view the full press release, visit http://nnw.fm/4YsD9

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday’s trading session at $3.80, up 4.1096%, on 13,255 volume. The average volume for the last 3 months is 11,390 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) was highlighted today in a publication examining how there's so much interest some analysts say the psychedelics industry could be as much as $5 billion annually. "I have seen some investment groups out there who have invested $100 million in the last 12 to 24 months," says Tim Regan, vice president of capital markets for KCSA Strategic Communications, as quoted by The Growth Op.

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Thursday’s trading session at $0.72, up 4.3478%, on 1,021,021 volume. The average volume for the last 3 months is 201,044 and the stock's 52-week low/high is $0.221/$0.998300015.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Dedicated to transforming energy conversion to improve the performance, efficiency and longevity in electric motors, Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) has developed and commercialized an electric power module (EPM) that integrates into electric motor systems to make them smarter. XRO’s emphasis for 2020 is to focus on moving forward with the commercialization of its exclusive technology.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Thursday’s trading session at $0.37, up 5.9777%, on 119,948 volume. The average volume for the last 3 months is 130,336 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its entry into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 1,396,826 shares of its common stock. To view the full press release, visit http://nnw.fm/64G4x

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Thursday’s trading session at $1.29, off by 14.00%, on 2,206,635 volume. The average volume for the last 3 months is 778,988 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQX: PLPRF) on Wednesday announced that after markets close on Thursday, May 7, the company will report its audited financial results for the fourth quarter and full year ending December 31, 2019. In addition, the company will also be hosting a conference call and webcast to discuss the financial results and recent corporate highlights on May 7 at 5 PM ET. Plus co-founder and CEO Jake Heimark and chief financial officer Jon Paul will also be conducting a question and answer session on the call. To join the call, dial (866) 220-4156 for the US and Canada toll-free line or (864) 663-5231 for the international line and request the Plus Products earnings call or provide conference ID: 2867687. To view the webcast, visit the website at least 15 minutes prior to the call to register, download, and install any necessary audio software (http://cnw.fm/I0kSs). After the call is finished, there will be an archived audio webcast available for replay on the company’s website. To view the full press release, visit http://cnw.fm/MyID0

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Thursday’s trading session at $0.49, off by 1.4085%, on 17,888 volume. The average volume for the last 3 months is 40,795 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

Fear of catching COVID-19 is causing many commuters to turn their eye to the auto market, to purchase a vehicle instead of taking a bus. But they are increasingly afraid of crowded dealerships. If COVID-19 has taught us anything, it is that the future of auto sales is online, and PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) is among the pioneers of this trend. Also today, the company announced that it has secured a further USD $600,000 from Texas-based D&P Holdings, Inc. ("D&P"). According to the update, the company, due to having sufficient operational funds, has made a strategic decision not to draw down further at this time from D&P, which has committed up to USD $10 million. To view the full press release, visit http://nnw.fm/J4i0y

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Thursday’s trading session at $0.0968, off by 7.4127%, on 250 volume. The average volume for the last 3 months is 40,795 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was featured today in the 420 with CNW by CannabisNewsWire. The past few years have been instrumental for cannabis. It has seen a slew of positive legislative changes and more states are willing to look at it objectively, especially in regard to its potential medical benefits. Although the science to back this up is scarce, we now know without a doubt that cannabis produces chemicals called cannabinoids, and they are responsible for its therapeutic abilities.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday’s trading session at $0.00525, off by 0.943396%, on 5,377,227 volume. The average volume for the last 3 months is 6,028,125 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)

The QualityStocks Daily Newsletter would like to spotlight iClick Interactive Asia Group Ltd. (NASDAQ: ICLK).

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it will report its unaudited first quarter 2020 financial results before the U.S. market opens on Friday, May 22, 2020. According to the update, the company's management team will host a conference call at 8:00 AM ET (8:00 PM Hong Kong Time) on May 22 to discuss its business and financial performance. To view the full press release, visit http://nnw.fm/7Bupq

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider connecting worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping international and domestic marketers reach their target audiences. Headquartered in Hong Kong, iClick operates in 10 locations worldwide, including Asia and Europe.

iClick aims to become a fully integrated Enterprise and Marketing Cloud Platform in China, providing clients a full consumer-cycle solution. This is facilitated by two pillars’ growth strategy through two business segments: Marketing Solutions and Enterprise Solutions.

Marketing Solutions

Using data and AI-driven technology to help brands efficiently identify, target and acquire the right customers

As the leading programmatic marketing platform in China, iClick’s proprietary platform collects a wealth of data from multiple sources to precisely reach the right audience at the right moment, on the right channel and right device. Cross-screen search solutions capture critical micro-moments when users proactively search for what they need. This multi-dimensional approach to marketing allows iClick to effectively understand internet users and exponentially widen target audiences for its brand clients. Multiple monetization models available in the Marketing Solutions segment allow iClick to serve its clients in several ways, such as audience targeting.

Data-driven marketing is indispensable to marketers targeting specific audiences in China. More than 825 million internet users in China are anonymously profiled on iClick’s platform, which boasts cross-channel and cross-screen capabilities.

Enterprise Solutions

Enabling brands to efficiently manage their consumers through online and offline data integration and analysis, increase the repurchase rate, and enhance consumers’ loyalty

iClick’s Enterprise Solutions segment addresses enterprise needs in China, particularly focusing on “smart retail,” an expanding and innovating market involving the combination of online and offline consumers’ behavioral information. Enterprise Solutions support detailed profiling of customers, which facilitates data-driven business strategies, enhances business processes at various levels, and increases operational and marketing efficiency.

Enterprise Solutions leverages iClick’s proprietary platform that incorporates Artificial Intelligence (AI) to learn, build and store knowledge, enabling accurate predictions about consumer behavior that ultimately provide marketing solutions derived from the large amount of available data.

Through a strategic partnership with Tencent, iClick’s Enterprise Solutions presents strong recurring revenue streams with tremendous opportunities to upsell multi-national corporations (MNCs). Tencent’s proprietary API connection enables brands to build 360-degree consumer profiles based on the collection and integration of purchased behavioral information from online and offline touchpoints, including WeChat Mini Programs, WeChat Payment, WeChat Work and more.

As iClick continues to provide integrated marketing and smart retail solutions targeting Chinese consumers, the company believes Enterprise Solutions has strong long-term growth potential and will become a major gross margin contributor in the future.

Partnerships

In 2019, iClick established various agreements and partnerships with a number of leading southeast and northeast Asian companies for regional diversification and in 2020 is focused on continuing to develop additional partnerships and new business models globally. Many of the world’s top companies are leveraging iClick’s proprietary data platform to precisely identify and reach out to core target audience groups in China.

The company’s partnerships include:

  • A tri-partnership with BTG WELINK, an online retail services arm of Beijing Tourism Group (“BTG”), and Tencent Holdings Ltd., China’s leading provider of internet value added services. As part of this partnership, iClick applies its upgraded solutions to build a private DSP (Demand Side Platform) system for BTG. Using Tencent’s big data advertising platform, iClick can assist BTG to develop precision marketing campaigns.
  • An Advertising Agency Authorization Certificate from Baidu Inc. (NASDAQ: BIDU), under which iClick is designated the authorized agency for native advertising of Baidu’s news feed ads. Native advertising is a consumer-friendly, non-disruptive advertising format that has gained rapid popularity among advertisers in recent years. Native advertising and creative marketing content have become a more effective marketing method among the Chinese young consumers. In 2019, the native advertising sector was estimated to have an around 53.5% share of the online advertising revenue, according to Statista.
  • A joint-venture partnership with VGI Global Media Plc (VGI.BKK), Thailand’s No. 1 online to offline (O2O) solutions provider across advertising, payment and logistics platforms, which enables brands in Southeast Asia to capture the multi-billion-dollar Chinese consumer market through a range of technology-driven marketing solutions.

Case Study: Armani Hotel Dubai

Dubai has been gearing up to welcome the growing wave of Chinese visitors. Chinese nationals are eligible for a 30-day visa-on-arrival into the UAE, which gives Chinese travelers tremendous convenience. In light of this, Armani Hotel Dubai set the objective to increase its sales in this market.

The challenge: What Aarmani Hotel Dubai lacked in executing this goal was insightful understanding of Chinese travelers in particular the demographics that were likely to be attracted to the hotel. Challenged by the huge differences in the business practice, unique culture and language barrier in running digital campaigns in China, Armani Hotel Dubai turned to iClick’s know-how and expertise to guide its campaign to success and meet its sales goal.

The solution: iClick tailored an optimal solution for the hotel to increase brand awareness and booking rate from China – which is the key market for the hotel – and successfully assisted Armani Hotel Dubai in reaching its target Chinese audiences by using China’s most popular mobile and internet sites, including WeChat and Weibo, to improve reach and booking potential.

The results: Due to iClick’s unrivaled technological and execution strengths, Armani Hotel Dubai’s ads were delivered in an omnichannel manner, raising brand awareness and garnering interest between Chinese consumers. Subsequently, Armani Hotel Dubai saw a surge in conversion rate.
During the campaign, the Armani Hotel Dubai brand was connected with 87% of Chinese mobile users.

Award-winning Provider

iClick, a Deloitte Technology Fast50, has received multiple industry awards from the international marketing community. The company is committed to helping clients access digital China with its omni-channel, data-driven marketing solutions that deliver uniquely sharpened marketing capabilities and outstanding advertising results.

Most recently, iClick subsidiary OptAim (Beijing) Information Technology Co., Ltd was recognized by Tencent Ads as a 2019 Gold Service Provider. Tencent Ads also named OptAim the winner of three major annual awards for the second half of 2019: “Outstanding Contribution of the Year,” “Best Technology & Data Application Award,” and “Best Branding Awards.”

In November 2019, company co-founder and CEO Sammy Hsieh was chosen as the winner of the “EY Entrepreneur of The Year China 2019 Award in Technology Category,” an award recognizing his entrepreneurial acumen, innovative spirit and strong leadership. As one of the world’s most prestigious business accolades, the “EY Entrepreneur of The Year” awards program honors those who accomplish success by combining ability with opportunity, and inspire others with great vision, leadership and outstanding achievement.

iClick won the Annual Influential Platform Award and the Innovation Golden Award in Marketing at the Creative Award 2019, as well as the Best Tourism Marketing Agency. The company was also the recipient of the “Best Brand and Performance Marketing Award” at the Performance Marketing Ecosystem Summit 2018 hosted by the Advertising & Marketing Service, a division of Tencent Holdings Limited.

The company in 2018 was also recognized as “Platinum Service Partner of Tencent Social Ads” at the Tencent Key Accounts Mid-Year Summit held in Beijing. The mobile division of iClick, Optaim, received the same award beginning in 2016. Optaim was also the “Best DSP Partner” and “Key Account Data Partner” of Tencent, making it the only player in China with such unique and deep level of cooperation with Tencent Social Ads.

Leadership

Sammy Wing Hong Hsieh, chairman of the board and co-founder, was CEO from 2009 to 2019. Prior to co-founding iClick, Hsieh held senior positions in several prominent technology companies. He was general manager for Asia Pacific at Efficient Frontier (now an Adobe company), a leading digital performance marketing company, and was director of Search Marketing at Yahoo Hong Kong from 2000-2008. Hsieh received a bachelor’s degree in economics from the University of California, Los Angeles.

Jian Tang, director, CEO and co-founder, has 20 years of experience in digital advertising and is well-known in China for his expertise in advertising technologies and big data. In 2012, he founded OptAim, which was acquired by iClick in 2015, and has served key research, engineering and management roles at Yahoo’s global research and development center. Tang received his doctorate in computer engineering from Tsinghua University and was named by Campaign Asia as one of the leaders in its Digital A-List in 2016.

Terence Chi Wai Li, chief financial officer, has 15 years of experience in financial management, investment and business operations. He has served in management roles and advisory capacities at several start-ups, in addition to financial management and fundraising roles. He previously worked at PricewaterhouseCoopers, specializing in M&A due diligence and cross border tax and deal structuring projects. Li received an MBA from Oxford University’s Said Business School. He is a Fellow Member of ACCA, a Member of HKICPA, and a Chartered Financial Analyst.

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK), closed Thursday’s trading session at $4.66, up 1.0846%, on 416,340 volume. The average volume for the last 3 months is 289,701 and the stock's 52-week low/high is $2.73000001/$5.48999977.

Recent News

chart

Cannabis Global, Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (MCTC).

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced a new marketing and informational agreement with the medical cannabis online media company RXLeaf.com. Under the agreement, RXLeaf will market various Cannabis Global products under its respective brands as well as under Cannabis Global’s Hemp You Can Feel(TM) branding. The agreement will put MCTC’s products in front of thousands of RxLeaf's online members, with visitors that include doctors, patients, researchers, advocates, and distributors. To view the full press release, visit http://cnw.fm/flw0M

Cannabis Global, Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

Cannabis Global, Inc. (MCTC), closed Thursday’s trading session at $0.235, up 2.1739%, on 58,824 volume. The average volume for the last 3 months is 15,875 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced its receipt of Health Canada's approval for the totality of its main Valleyfield hybrid greenhouse. According to the update, TGOD has the flexibility, with all twenty-four zones now licensed, to quickly expand its operations at Valleyfield as the market develops. The company also plans to leverage parts of the newly licensed space to shift a portion of its processing activities currently being handled at Ancaster or intended to be outsourced to third parties. This will assist the company in optimizing costs, accelerating supply chain timelines and reducing bottlenecks in production of high-demand products such as infusers and teas. To view the full press release, visit http://cnw.fm/rGd5s

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Thursday’s trading session at $0.19, up 4.3956%, on 622,042 volume. The average volume for the last 3 months is 1,063,282 and the stock's 52-week low/high is $0.150000005/$3.23000001.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW; OTCQB: CANSF) announces changes to its management team with the promotion of Dr. Chris Savile to Chief Operations Officer and the departure of Dr. Peter Facchini, Chief Scientific Officer, and Dr. Jill Hagel, Vice President, Applied Science, effective immediately.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Thursday’s trading session at $0.30, even for the day, on 43,180 volume. The average volume for the last 3 months is 8,321 and the stock's 52-week low/high is $0.239999994/$1.50.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced the sale of a prototype of its QuadSight(R) four-camera vision system to a leading, multi-billion dollar European Tier One supplier of subsystems for rail and commercial vehicles. According to the update, the sale followed successful live technological demonstrations in Germany. “In 2019, Foresight identified the commercial vehicle industry as a new market suitable for the Company's unique technology. To view the full press release, visit http://nnw.fm/a5IdH

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Thursday’s trading session at $0.89, off by 1.766%, on 7,571,157 volume. The average volume for the last 3 months is 306,648 and the stock's 52-week low/high is $0.460999995/$2.94000005.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a Canadian leader in the cannabis industry, recently announced two key assets – its 440,000-square-foot, state-of-the-art cultivation 7ACRES plant and its 12,000-square-foot Blissco extraction structure – have been completed and received final approval and licensing for operation. This milestone step makes Supreme one of the few Canadian producers that operates fully constructed and licensed cultivation and extraction facilities.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday’s trading session at $0.18155, off by 0.79235%, on 154,829 volume. The average volume for the last 3 months is 570,624 and the stock's 52-week low/high is $0.101000003/$1.54999995.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.